MeiraGTx Holdings plc (MGTX) Stock Price

9.48 ▼ -1.77 (-15.73%)
Open: 9.55 Vol: 4.42M Day's range: 8.77 - 10.05 Apr 16, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MGTX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 9.40▲ 9.33▲ 9.36▲ 10.12▼ 8.49▲
MA10 9.36▲ 9.29▲ 9.90▼ 9.76▼ 7.93▲
MA20 9.38▲ 9.98▼ 10.58▼ 8.79▲ 7.93▲
MA50 9.30▲ 10.32▼ 9.85▼ 8.02▲ 7.64▲
MA100 9.72▼ 9.82▼ 9.27▲ 7.98▲ 6.62▲
MA200 10.51▼ 9.16▲ 8.39▲ 8.04▲ 6.58▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.013▲ -0.049▼ -0.236▼ 0.158▲ 0.182▲
RSI 61.580▲ 40.035▼ 40.914▼ 55.680▲ 63.797▲
STOCH 75.924     53.281     19.908▼ 71.026     58.001    
WILL %R -3.509▲ -73.156     -78.167▼ -48.978     -45.314    
CCI 177.306▲ -8.713     -61.004     14.651     243.217▲
Latest Filters Detected On MGTX
▼ RSI $MGTX RSI(14) Crossed Below 70 Set Alert
MA $MGTX Price Crossed Below MA(13) Set Alert
MA $MGTX Price Crossed Below MA(7) Set Alert
▼ GAP $MGTX Open Gap Down %5 Set Alert
▼ GAP $MGTX Open Gap Down %3 Set Alert
▼ GAP $MGTX Open Gap Down %2 Set Alert
MeiraGTx Holdings plc News
MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares
Thursday, April 16, 2026 05:15 AM
MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the pricing of an underwritten offering of 11,111,111 of its ordinary shares at ...
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
Thursday, April 16, 2026 04:33 AM
Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP ...
MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia
Thursday, April 16, 2026 04:18 AM
Clinically meaningful improvements in xerostomia symptoms measured by PRO Xerostomia Questionnaire (XQ) maintained out to 3 years post treatment ...
MGTX historical stock data
date open high low close volume
16/04/26 9.55 10.05 8.77 9.48 4,423,924
15/04/26 11.32 11.8499 11.07 11.25 642,899
14/04/26 9.78 11.59 9.725 11.29 1,186,061
13/04/26 8.99 9.65 8.986 9.63 428,570
10/04/26 9.36 9.43 8.875 8.97 502,527
09/04/26 9.25 9.50 9.222 9.34 391,941
08/04/26 9.52 9.705 9.3002 9.39 702,565
07/04/26 9.36 9.52 9.10 9.51 621,217
06/04/26 9.21 9.88 9.1503 9.52 1,129,665
02/04/26 8.89 9.42 8.89 9.18 1,094,807
Quote Details
52wk Low:4.55
52wk High:11.85
Vol:4.42M
Avg Vol(3m):10.2M
1Y Chng:+30.76%
1M Chng:+35.62%
Add to Watch List
More Information
Index US Composite
Market Cap. 916.27M